Genetic variations in CC chemokine receptors and hypertension.

[1]  G. Mensah,et al.  Prevalence of Heart Disease and Stroke Risk Factors in Persons With Prehypertension in the United States, 1999-2000 , 2004 .

[2]  A. Takeshita,et al.  Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling , 2004, Circulation research.

[3]  H. Izawa,et al.  Prediction of Genetic Risk for Hypertension , 2003, Journal of cardiology.

[4]  G. Ricciardi,et al.  CCR5 and CCR2 gene polymorphisms in hypertensive patients , 2003, British journal of biomedical science.

[5]  T. Kenakin,et al.  CCR5 chemokine receptors: gatekeepers of HIV-1 infection. , 2002, Current drug targets. Infectious disorders.

[6]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[7]  S. O’Brien,et al.  The effect of genetic variation in chemokines and their receptorson HIV transmission and progression to AIDS , 2000, Immunological reviews.

[8]  J. Wilcox,et al.  CC Chemokine Receptor 2 Is Required for Macrophage Infiltration and Vascular Hypertrophy in Angiotensin II–Induced Hypertension , 2000, Hypertension.

[9]  J. Goedert,et al.  Phenotypic Expressions of CCR5-Δ32/Δ32 Homozygosity , 1999 .

[10]  P. Morin,et al.  High-throughput single nucleotide polymorphism genotyping by fluorescent 5' exonuclease assay. , 1999, BioTechniques.

[11]  Anthony S. Fauci,et al.  Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.

[12]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[13]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[14]  L. Berkman,et al.  Genetic susceptibility to death from coronary heart disease in a study of twins. , 1994, The New England journal of medicine.